APA (7th ed.) Citation

A, H., SE, K., P, R., KD, A., JD, G., CJ, B., & MP, F. (2022). Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling. ACS pharmacology & translational science, 5(11), 1062. https://doi.org/10.1021/acsptsci.2c00153

Chicago Style (17th ed.) Citation

A, Huang, Kurhade SE, Ross P, Apley KD, Griffin JD, Berkland CJ, and Farrell MP. "Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling." ACS Pharmacology & Translational Science 5, no. 11 (2022): 1062. https://doi.org/10.1021/acsptsci.2c00153.

MLA (9th ed.) Citation

A, Huang, et al. "Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling." ACS Pharmacology & Translational Science, vol. 5, no. 11, 2022, p. 1062, https://doi.org/10.1021/acsptsci.2c00153.